Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Zollinger-Ellison Syndrome 1Lymphoproliferative Disorders 1Lymphomatoid Granulomatosis 1Lymphoma, Non-Hodgkin 1Lymphoma 1Epstein-Barr Virus Infections 1Adenoma, Islet Cell 1

Interventions

Streptozocin 2Specimen Handling 2Magnetic Resonance Spectroscopy 2sapanisertib 1lutetium Lu 177 dotatate 1cabozantinib 1aflibercept 1X-Rays 1Sunitinib 1Phantoms, Imaging 1Melphalan 1Interferons 1Fluorouracil 1Doxorubicin 1Cisplatin 1Capecitabine 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Adenoma, Islet Cell × Interferons × Clear all
NCT00001228 2017-07-02

Interferon and Octreotide to Treat Zollinger-Ellison Syndrome and Advanced Non-B Islet Cell Cancer

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
50 enrolled

Adenoma, Islet Cell, Zollinger-Ellison Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡